You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

The following information leaflet is available:

Information for Patients (Patient Card) (May 2019)

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Volibris is a registered trademark of Gilead, used under licence by the GlaxoSmithKline Group of Companies.